A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate on the Hepatic Uptake, Pharmacokinetics, Safety
and Tolerance of a New Oral Pentamidine Formulation in Hepatocellular Carcinoma Subjects
Undergoing Thermal Ablation